Data Dictionary: Belgian Cancer Registry: Difference between revisions

Revision as of 17:51, 29 May 2024

Go back to Belgium page

Table 1: Patient Information and Treatment Data.

Unique patient identification including demographic parameters (i.e., date of birth, zip code)
Unique identification of the care program and hospital
Diagnosis according to international classification
Date of incidence
Tumor stage (cTNM)
Conclusion of the pathological report (including pTNM)
Treatment with reference to guidelines or justification of deviation
Follow-up plan
Side effects
Disease-free survival and survival (i.e., treatment outcome)
Date of death
Gender
Region
Incidence year
5-year age group (only for absolute numbers and gross incidence)

Source: Click here to learn more.

Table 2: Screening Variables.

Aspects of Participation and Screening Test Usage
Aspects of participation
Use of the screening test in the target group
Results obtained and their use (including cancer detection rate, sensitivity, and specificity)
Cyto-histopathology register
Results of further follow-up

@@ Line 3: / Line 3: @@
 Source: [https://kankerregister.org/nl/kankerdiagnoses Click here to learn more].
+'''Table 1:''' Patient Information and Treatment Data.
 {| class="wikitable"
-|+ Patient Information and Treatment Data
 |-
-! Variable !! Description
+| Unique patient identification including demographic parameters (i.e., date of birth, zip code)
 |-
-| Unique patient identification including demographic parameters || (i.e., date of birth, zip code) and unique identification of the care program and hospital
+| Unique identification of the care program and hospital
 |-
-| Diagnosis according to international classification || including date of incidence
+| Diagnosis according to international classification
 |-
-| Tumor stage (cTNM) ||
+| Date of incidence
 |-
-| Conclusion of the pathological report || (including pTNM)
+| Tumor stage (cTNM)
 |-
-| Treatment with reference to guidelines or justification of deviation ||
+| Conclusion of the pathological report (including pTNM)
 |-
-| Follow-up plan ||
+| Treatment with reference to guidelines or justification of deviation
 |-
-| Side effects ||
+| Follow-up plan
 |-
-| Disease-free survival and survival || (i.e., treatment outcome)
+| Side effects
 |-
-| Date of death ||
+| Disease-free survival and survival (i.e., treatment outcome)
 |-
-| Gender  || (Male – Female – Both sexes together)
+| Date of death
 |-
-| Region || (Belgium – Flanders – Wallonia – Brussels)
+| Gender
 |-
-| Incidence year ||
+| Region
 |-
-| 5-year age group || (only for absolute numbers and gross incidence)
+| Incidence year
+|-
+| 5-year age group (only for absolute numbers and gross incidence)
 |}
 Source: [https://kankerregister.org/nl/screening Click here to learn more].
+'''Table 2:''' Screening Variables.
 {| class="wikitable"
-|+ Screening Variables
 |-
 | Aspects of Participation and Screening Test Usage